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Molecular Cloning of Human Synovial Cell Collagenase and
Selection of a Single Gene from Genomic DNA
Constance E. Brinckerhoff, Peggy L. Ruby, Scott D. Austin, M. Elizabeth Fini, and Hillary D. White

Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire 03756

Abstract
We used a subclone of a rabbit genomic clone for collagenase
that cross-hybridizes with human synovial cell messenger RNA
(mRNA) to identify a human collagenase complementary DNA
(cDNA) clone. The human cDNA clone is 2.1 kilobases (kb)
and selects a mRNA transcript of approximately the same size
from primary cultures of rheumatoid synovial cells that produce
collagenase, but no mRNA is selected from control (nonproducing) synovial fibroblasts. Restriction enzyme analysis and
DNA sequence data indicate that our cDNA clone is full length
and that it is identical to that recently described for human skin
fibroblast collagenase. The cDNA clone identified a single collagenase gene of 17 kb from blots of human genomic DNA.
The identity of human skin and synovial cell collagenase and the
ubiquity of this enzyme and of its substrates, the interstitial collagens types I, II, and III, imply that common mechanisms controlling collagenolysis throughout the human body may be operative in both normal and disease states.

Introduction
The neutral proteinase collagenase (E.C. 3.4.23.7) is the only
enzyme able to initiate breakdown of the interstitial collagens,
types I, II, and III (see reviews [ 1, 2]). The fact that these collagens
are the body's most abundant proteins means that collagenase
plays a key role in the remodeling of collagen that occurs constantly in both normal and diseased conditions. Thus, mechanisms concerning the regulation of collagenase both at the level
of protein biochemistry and at the level of the gene are of prime
importance to our understanding of connective tissue metabolism.
Rheumatoid arthritis is a connective tissue disease in which
collagenase is a major mediator of pathology (3). In rheumatoid
arthritis, synovial cells lining the joint proliferate into a huge
mass which secretes large quantities of collagenase and invades
and destroys cartilage, tendon, and bone. Normally, these cells
synthesize and secrete only minimal amounts of collagenase,
but in the disease state, they are stimulated by phagocytosis (4),
cell fusion (5), and mediators such as interleukin 1 (6, 7) and
crystals of monosodium urate monohydrate (8) to produce large
quantities of enzyme. Here we develop and characterize a complementary DNA (cDNA) clone for human synovial cell collagenase. We show that this cDNA clone cross-hybridizes with
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rabbit collagenase messenger RNA (mRNA) and is identical to
a cDNA for human skin collagenase. We further use this cDNA
clone to provide data consistent with the existence of a single
collagenase gene in the human genome.

Methods
Cell culture. Specimens of rheumatoid synovial tissue, obtained from
the operating room of the Mary Hitchcock Hospital (Hanover, NH),
were dissociated into a single-cell suspension by sequential treatment
with bacterial collagenase and trypsin (9). Cells were plated at 50% confluency in 100-mm diam culture dishes in 20% fetal calf serum (Gibco,
Grand Island, NY). After 7-10 d, when the cells had become confluent,
they were washed three times with Hanks' balanced salt solution and
placed in serum-free medium supplemented with 0.2% lactalbumin hydrolysate. In some experiments, primary cultures were trypsinized (0.25%;
Gibco) and passaged in Dulbecco's modified Eagle's medium with 10%
fetal calf serum. At confluence, they were also transferred to serum-free
medium. In contrast to primary cultures of rheumatoid synovial cells,
these cells do not make collagenase (9) and hence, they served as a negative
control. After 24-48 h in serum-free conditions, medium was assayed
for collagenase activity in a standard fibril assay with ['4C]collagen fibrils
(10-12) and the RNA was harvested as described previously (13, 14).
Construction and screening of a human synovial cell cDNA library
for collagenase in bacteriophage X-gtJ l. RNA was harvested from primary
cultures of rheumatoid synovial cells derived from three individuals.
Cells were cultured in serum-free medium and were shown to be synthesizing collagenase by means of the collagen fibril assay (see above).
Poly A+ RNA was isolated by oligo dT-cellulose chromatography (13,
15). 6 jsg of poly A+ RNA served as a template for cDNA synthesis,
carried out as described by Gubler and Hoffman (16). After ligation to
linkers containing the Eco RI restriction site, the cDNA was cloned into
bacteriophage X-gtl 1, purchased from Promega Biotec (Madison, WI),
according to the manufacturer's instructions. A cDNA library containing
1.6 X 104 recombinants was generated and was amplified once.
The library was plated at I04 recombinants per 100-mm diam culture
plate and screened for clones containing collagenase sequences by means
of in situ plaque hybridization (17) using a rabbit collagenase genomic
subclone, p206, known to cross-hybridize with human synovial cell
mRNA (18). Duplicate plaque lifts onto Gene Screen Plus (New England
Nuclear, Boston, MA) were made from each plate of recombinants and
were probed with p206 insert radiolabeled with 32P by the oligolabeling
method of Feinberg and Vogelstein (19). Hybridizations were performed
exactly as described (20).
DNA from three-time plaque-purified recombinants was prepared
as described (17). Clone inserts were restriction mapped by single and
multiple analysis of the products of restriction enzyme digestions on
agarose gels ( 17).
DNA sequencing. The entire Eco RI-digested human collagenase
cDNA clone, termed hu-col 16, was ligated with linearized Ml 3mp19
vector and transfected into bacterial strain JM101 (21). A clone containing
the noncoding strand of the 0.3-kb Eco RI fragment was isolated and
sequenced by the dideoxynucleotide termination method (22). Multiple
sequence determinations were made to ensure accuracy of analysis from
this single strand.
Northern and Southern blot analysis. For Northern blot analysis, 25
gg of whole-cell RNA from collagenase-producing human synovial cells

(i.e., primary cultures) or nonproducing cells (i.e., passaged cultures) was
electrophoresed at 4VC in a 1% agarose gel containing 2.2 M formaldehyde
and transferred to Gene Screen Plus (17, 20). RNA was harvested from
rabbit synovial cells that had been induced to synthesize collagenase by
treatment with 10-8 M phorbol myristate acetate (13). The blot was
probed first with the hu-col 16 cDNA radiolabeled with 32P by nick
translation (17). The blot was then stripped by boiling for 10' in 0.1
X standard saline citrate and the effectiveness of the stripping procedure
was checked by an overnight exposure with XAR-5 film (Eastman Kodak
Co., Rochester, NY). It was then probed with rabbit activator cDNA
(23), which had been removed in toto from vector with Eco RI and
labeled with 32p (19). Hybridizations were as detailed (17, 20).
Human genomic DNA for Southern blot analysis was prepared from
peripheral blood lymphocytes separated from freshly drawn venous blood
by unit gravity sedimentation through dextran/EDTA, following the
methods of Aldridge et al. (24). 10 ,g of each DNA sample was digested
overnight at 370C with appropriate enzymes (Boehringer Mannheim,
Indianapolis, IN) and run into an 0.8% agarose gel with Tris/borate/
EDTA buffer (17). The electrophroresis was carried out at 70 V for 4 h
at 4VC with recirculation of buffer. Gels were then blotted onto Gene
Screen Plus as described for Southern blots. After blotting, they were
probed with either the 0.3-kb Eco RI fragment, representing the 5' end
of the collagenase cDNA (see below), or the 1.75-kb Eco RI fragment
containing the rest of the cDNA insert with its 3' end. Probes were labeled
by oligolabeling (19) and hybridized (17, 20).

Results
Identification of a cDNA clone for human synovial cell collagenase. To screen the cDNA library for a clone for human synovial
cell collagenase, we took advantage of the fact that an Eco RI
fragment of a rabbit genomic clone for collagenase cross-hybridized with human mRNA (18). This fragment, termed p206,
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has been subcloned into pBR328 (18) and was used to screen 5
X 104 human recombinants. From these, 12 potential positives
were identified and one clone, termed lambda hu-col 16, was
purified through three rounds of plaque purification. The insert
is approximately 2.1 kb and has the restriction map shown in
Fig. 1 A.
One strand of the 0.3-kb Eco RI fragment was sequenced as
described in Methods and was shown to contain 297 bases of
cDNA. The 5' end of the sequence was identified by the position
of the artificially added Eco RI linker. We analyzed the DNA
sequences using a program for the Apple McIntosh called "The
DNA Inspector" (25). A single, long, open reading frame was
found, and the encoded amino acids are shown under the DNA
sequence in Fig. 1 B. The sequence begins at base 68 of the
cDNA, with a methionine start codon, and continues for 70
amino acids until the end of the cDNA fragment cloned into
M 13 was reached. Surrounding the methionine codon is a DNA
sequence consistent with the consensus identified for efficient
translation initiation (26). The putative 5' untranslated region
ofthe clone consists of 67 bases capped at the 5' end with a short
direct repeat of 5 bases (CGGCA). Because sequence rearrangements are often found in cDNAs synthesized from regions
around the cap sites of mRNAs, we suspect that the direct repeat
is a cloning artifact (27).
While this work was in progress, the complete sequence of
human skin collagenase cDNA was published (28). The cDNA
sequence that we had obtained is identical to that of the skin
collagenase except for the first 10 bases at the 5' end ofthe cDNA,
which includes most of the direct repeat.
Generation of a restriction map for the human skin sequence
and comparison to the restriction map of human synovial cell

Figure 1. Human synovial cell collagenase cDNA. (A) restriction map.
(B) Sequence of the 5' end of the human synovial cell collagenase
cDNA. The sequence is the 0.3-kb Eco RI fragment of the clone
lambda hu-col 16 and is that of the mRNA strand written 5' -o 3'.
The primary structure of the putative protein encoded by the cDNA is
written under the nucleic acid sequence. A box is drawn around the
region that is different from the reported sequence of human skin collagenase (28) and a line is drawn under the direct repeats that probably represent a cloning artifact (32).
-
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Figure 2. Northern blot analysis of human synovial
cell mRNA. Whole-cell RNA was harvested from collagenase-producing human and rabbit synovial fibro-
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collagenase cDNA also showed no differences. These data
strongly suggest that the mRNA for human skin and human
synovial cell collagenase were synthesized from the same gene.
Identifcation of human synovial cell collagenase mRNA.
When lambda hu-col 16 was used to probe Northern blots, it
selected a single mRNA band of 2.2 kb from RNA derived from
primary rheumatoid synovial cells that were producing collagenase. No band was selected from RNA from control cultures
of human synovial fibroblasts that were not synthesizing collagenase (Fig. 2 A). Cross-hybridization between rabbit mRNA
and human collagenase cDNA was also noted.
Cross-hybridization of rabbit activator cDNA with human
mRNA. We have recently isolated a full-length cDNA clone for
rabbit activator, a metalloproteinase responsible for the activation of latent rabbit procollagenase (23, 29-31). By DNA sequence analysis (29), rabbit activator shows 77% homology to
rat transin, an oncogene transformation-induced protein (32),
and it is possible that transin may be the functional equivalent
of activator in the rat. To determine whether a similar protein
may exist in populations of rheumatoid synovial cells, we first
stripped and then reprobed the Northern blot described above
with rabbit activator cDNA. Fig. 2 B shows that rabbit activator
cDNA hybridized strongly with rabbit mRNA, selecting a band
of 1.9 kb. In addition, the cDNA selected a human mRNA,
also of 1.9 kb, from primary, collagenase-producing cultures but
not from noncollagenase-producing passaged cells. Note that
this band is distinct from that detected by the human collagenase
cDNA, but that it appears to be coordinately regulated with
collagenase mRNA inasmuch as both are present in primary
cultures but not in passaged ones.
Detection of the gene for human synovial cell collagenase.
Human genomic DNA from 11 individuals, five of whom are
members of one family, was digested with a battery ofrestriction
enzymes, electrophoresed and blotted, and then probed with the
1.7- and 0.3-kb Eco RI fragments of lambda hu-col 16 cDNA
clone. Fig. 3 shows one example of our studies in which genomic
DNA from all 11 individuals was digested with Eco RI and

9
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In individual 7, two additional fragments of 1.1 and 0.6 kb were
also present. When the blot was probed with the 0.3-kb cDNA
fragment, a band of 0.3 kb was detected in all samples (data
not shown). In that these bands add up to 17 kb, it is tempting
to hypothesize that individual 7 has two collagenase alleles, one
with an additional Eco RI site within the 1.7-kb fragment.
Digestion of genomic DNA from these same individuals with
SstI revealed the presence of fragments of 15 and 2.2 kb whereas
digestion with Bam gave fragments of 10.9 and 6 kb. These data
-

a%

15 kb

-9

86-

-7

-5

4-

-3

WOOS

2-

a -1.5

*@mo

_

s

This probe detected 15- and 1.7-kb fragments in all individuals.
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1.7 kb

1.1 kb

-

probed with the 1.75-kb fragment of the hu-col 16 cDNA clone.

syno-

vial fibroblasts, electrophoresed in an agarose-formaldehyde gel, blotted onto Gene-Screen Plus and probed
with 32P-labeled cDNAs. (A) Probes with human collagenase cDNA. Lane 1, Bethesda Research Laboratories RNA size ladder, 5 Mg; lane 2, rabbit RNA from
collagenase-producing cells, 25 Mg; lane 3, human
RNA from collagenase-producing cells, sample 1, 25
Mig; lane 4, human RNA from collagenase-producing
cells, sample 2, 25 Mg; lane 5, human RNA from control cells, 25 Ag. (B) Probes with rabbit activator
cDNA. Lane 6, RNA size ladder, 5 Mg; lane 7, same as
lane 2; lane 8, same as lane 3; lane 9, same as line 4;
lane 10, same as lane 5.

0.3- o3

0.3 -

blasts and from control (nonproducing) human

0.6kb

v -tS
05
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std
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Figure 3. Southern blot analysis of human genomic DNA probed with
human collagenase cDNA. 10 Mg of genomic DNA was digested with
Eco RI, electrophoresed in 0.8% agarose, blotted onto Gene Screen
Plus, and then probed with 32P-labeled 1.75 Eco RI fragment of hu-col
16 cDNA. Lanes 7-11 represent DNA taken from members of one
family. Lanes 7 and 8 contain DNA from the parents, and lane 7 contains the DNA from an individual heterozygous for an Eco RI allelic
fragment.

are consistent with the hypothesis that there is a single gene of
17 kb for collagenase.
-

Discussion
Data amassed over the years have supported the concept that
human skin and synovial cell collagenase are related enzymes.
Synthesis of both can be induced (1-7, 33) and suppressed (3436) by the same compounds. Both have similar molecular weights
(28, 37, 38). Both are secreted as latent forms that are activated
by proteinases and organic mercurials and inactivated by nonspecific and specific metalloproteinase inhibitors (1, 2). Furthermore, recent evidence points to similar if not identical collagenases isolated from a variety of fibroblasts, including corneal
(39), gingival (40), and skin (37, 38), as well as from several
types of endothelial cells, such as brain capillary (41) and umbilical vein (42). However, these collagenases may be distinct
from the neutrophil collagenase (43) and from rat uterine collagenase (44, 45), which may be under different control mechanisms, and from type IV collagenase which exhibits different
substrate specificity (46). In this article we show, by restriction
enzyme analysis and by limited DNA sequence, that there are
no differences between synovial cell and skin fibroblast collagenase mRNAs, even in the 5' and 3' untranslated regions where
there is less selective pressure for sequence conservation (47).
We believe, therefore, that this constitutes exceedingly solid evidence that the two cDNAs are the product of the same gene.
Of interest is the fact that we have detected a single gene for
synovial cell/skin collagenase and that this gene appears to show
allelic variation. In the future it will be important to determine
whether the collagenase gene in certain individuals with particularly erosive rheumatoid arthritis or individuals with recessive
dystrophic epidermolysis bullosa, a disease of the skin in which
excess collagenase production is pathologically important (48),
contains restriction fragment length polymorphisms.
The confirmation of the identity at the level of nucleic acid
of human skin and synovial cell collagenase both solidifies our
previous biochemical knowledge and suggests important implications about the ubiquity of mechanisms regulating connective
tissue metabolism throughout the body. Collagenases can be
regulated by a variety of mechanisms. First, enzymatic activity
of active collagenase can be inhibited by such nonspecific inhibitors of enzymes such as a2-macroglobulin, or by specific
inhibitors of metalloproteinases, such as tissue inhibitor of
metalloproteinases (TIMP); both are ubiquitous (see reviews

[1, 2]).
A second controlling point for regulation of collagenase activity is in the enzymatic activation of latent procollagenase by
another metalloproteinase, proactivator (30, 31). At least in the
rabbit synovial cell system, conversion of procollagenase to an
enzymatically active form requires the presence of an activator
protein, which is, itself, secreted in latent form. Activation of

procollagenase depends, therefore, on a mini-cascade: the se-

quential activation of proactivator (by enzymes such as trypsin)
which then, in turn, activates latent procollagenase. The human
analogue ofactivator has not yet been documented although we
have detected a 1.9-kb transcript in human synovial cell mRNA
probed with rabbit activator cDNA (Fig. 2 B). In addition, Okada
et al. (49) have isolated three metalloproteinases from conditioned culture medium derived from human synovial cells and
one or more of these may be candidates for the human activator

protein(s).

A final control point for regulation of collagenase activity is
at the level of biosynthesis. Synthesis of collagenase can be induced by a variety of agents, such as interleukin 1 (6, 7), phorbol
esters (13), crystals of monosodium urate monohydrate (8) or

polyethylene glycol which induces giant-cell formation (5).
Conversely, biosynthesis can be antagonized by two classes of
compounds, the corticosteroids and the retinoids (34-36), as
well as by an autocrine (50). Recent data indicate first, that regulation occurs at the level of mRNA synthesis (13) and second,
that activator and collagenase are both coordinately induced
and suppressed (23). Thus we can begin to establish a family of
metalloproteinases that appear coordinately regulated and may
play a critical role in the modulation of connective tissues.
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